Ibere Pharmaceuticals Warrants
IBER.WS
IBER.WS was delisted on the 15th of February, 2023.
36 hedge funds and large institutions have $618K invested in Ibere Pharmaceuticals Warrants in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
9% more funds holding
Funds holding: 33 → 36 (+3)
20% less capital inflows, than outflows
Capital inflows: $87.2K | Capital outflows: $109K
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Clear Street
New York
|
+$31K |
| 2 |
EHP Funds
Toronto,
Canada
|
+$16.3K |
| 3 |
Cowen and Company
New York
|
+$15.9K |
| 4 |
AGM
Alpine Global Management
New York
|
+$10.6K |
| 5 |
Schonfeld Strategic Advisors
New York
|
+$9.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$52.5K |
| 2 |
PEAK6
Chicago,
Illinois
|
-$5K |
| 3 |
Lynwood Capital Management
Toronto,
Ontario, Canada
|
-$611 |
IBER.WS Hedge Fund Activity: Q2 2022 in Review
36 of the 5,961 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals Warrants (IBER.WS) for Q2 2022, worth a combined $618K — down 37% from $987K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new IBER.WS positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Clear Street, opening a new position worth an estimated $31K. The largest seller was Citadel Advisors, cutting an estimated $52.5K.
- 36 institutional investors held Ibere Pharmaceuticals Warrants (IBER.WS) as of Q2 2022, up from 33 in Q1 2022.
- Funds reported $618K of Ibere Pharmaceuticals Warrants stock for Q2 2022, down 37% quarter-over-quarter.
- 5 funds opened new Ibere Pharmaceuticals Warrants positions in Q2 2022 and 3 closed out, a net change of +2 holders.
- The largest Ibere Pharmaceuticals Warrants buyer in Q2 2022 was Clear Street, an estimated $31K added.
- The largest Ibere Pharmaceuticals Warrants seller in Q2 2022 was Citadel Advisors, an estimated $52.5K sold.
Based on aggregated 13F filings for Q2 2022.